Title
Clinical characteristics of pyrazinamide-associated hepatotoxicity in patients at a hospital in lima, peru
Other title
Características clínicas de la hepatotoxicidad asociada a la pirazinamida en pacientes de un hospital de lima, perú
Date Issued
01 July 2020
Access level
open access
Resource Type
journal article
Publisher(s)
Instituto Nacional de Salud
Abstract
In order to determine the characteristics of drug-induced liver injury (DILI), adult patients diagnosed with tuberculosis and with an anti-tuberculosis treatment scheme including pyrazinamide were studied. The re-exposure process was used for the cause-effect analysis of the DILI. A total of 10 patients were found with pyrazinamide-associated DILI; the median age and hospital stay were 40.5 years (from 22 to 76 years) and 41 days (from 11 to 130 days), respectively. The median time in which the events appeared was 14 days (from 3 to 46 days); jaundice was observed in 4 patients and radiological patterns such as hepatocellular, mixed and cholestatic were found in 5, 3 and 2 patients, respectively. Mild presentation of DILI was observed in 6 cases (60%) and moderate in 3 (30%). In conclusion, pyrazinamide-associated DILI required prolonged hospital stay, presented jaundice in little more than a third of the cases, and radiologically, the hepatocellular pattern predominated.
Start page
516
End page
520
Volume
37
Issue
3
Language
English
OCDE Knowledge area
Gastroenterología, Hepatología
Scopus EID
2-s2.0-85096303874
PubMed ID
Source
Revista Peruana de Medicina Experimental y Salud Publica
ISSN of the container
17264634
Sources of information: Directorio de Producción Científica Scopus